Literature DB >> 32448003

Prevalence and Diversity of Haplotypes of Sickle Cell Disease in the Eastern Province of Saudi Arabia.

Amein K Al-Ali1, Ahmed Alsulaiman2, Alhusain J Alzahrani3, Obeid T Obeid1, Chitti Babu Vatte1, Cyril Cyrus1, Awatif N Alnafie4, Rudaynah A Alali5, Mohammed Alfarhan2, Brian Mozeleski1, Martin H Steinberg6.   

Abstract

Hb F modulates sickle cell disease. Five major haplotypes of the β-globin gene cluster are associated with sickle cell disease. In the Eastern Province of Saudi Arabia, the Arab-Indian (AI) is most common. Single nucleotide polymorphism (SNP) genotyping (rs3834466, rs28440105, rs10128556, and rs968857) was carried out by nuclease allelic discrimination assay with target-specific forward and reverse primers, TaqMan probes, labeled with VIC and FAM. In 778 patients with sickle cell disease from the Eastern Province, a haplotype was assigned to 90.9% of all samples; 9.1% were classified as compound heterozygotes for the AI and an atypical haplotype. The distribution of haplotypes for 746 Hb S (HBB: c.20A > T) homozygotes was: 614 AI/AI, nine SEN/SEN (Senegal), 42 SEN/AI, nine CAM/CAM (Cameroon), one CAR (Central African Republic)/BEN (Benin), 71 AI/atypical. In Hb S/β-thalassemia (Hb S/β-thal), the distribution of Hb S haplotypes was: 22 AI/AI, one CAM/CAM, four AI/SEN, five AI/atypical. Mean Hb F in the haplotypes was: AI/AI 16.6 ± 7.5%, CAM/CAM 8.0 ± 4.1%, SEN/SEN 11.0 ± 5.1%, SEN/AI 15.1 ± 4.6%, AI/atypical 16.2 ± 6.5%. The presence of the SEN and CAM haplotypes was unexpected due to the apparent homogeneity of the population of the Eastern Province. We have successfully classified sickle cell disease haplotypes using the relatively inexpensive TaqMan assay for the first time. In addition, we have previously shown that children with AI haplotype have Hb F of 30.0% and mild disease, while in our cohort of adult AI patients, which might be the largest yet reported, Hb F was about 16.6%.

Entities:  

Keywords:  Anemia; Hb F; haplotypes; sickle cell disease; single nucleotide polymorphism

Mesh:

Substances:

Year:  2020        PMID: 32448003     DOI: 10.1080/03630269.2020.1739068

Source DB:  PubMed          Journal:  Hemoglobin        ISSN: 0363-0269            Impact factor:   0.849


  9 in total

Review 1.  Fetal hemoglobin in sickle cell anemia.

Authors:  Martin H Steinberg
Journal:  Blood       Date:  2020-11-19       Impact factor: 22.113

2.  Molecular Determination of Vascular Endothelial Growth Factor, miRNA-423 Gene Abnormalities by Utilizing ARMS-PCR and Their Association with Fetal Hemoglobin Expression in the Patients with Sickle Cell Disease.

Authors:  Abdullah Hamadi; Rashid Mir; Ali Mahzari; Abdulrahim Hakami; Reema Almotairi; Gasim Dobie; Fawaz Hamdi; Mohammed Hassan Nahari; Razan Alhefzi; Mohammed Alasseiri; Nora Y Hakami; Hadeel Al Sadoun; Osama M Al-Amer; Jameel Barnawi; Hassan A Madkhali
Journal:  Curr Issues Mol Biol       Date:  2022-06-01       Impact factor: 2.976

3.  Effects of -3.7α Deletion and Sickle-Cell Trait on Ventilatory and Hemodynamic Responses to Maximum Exercise in Young Saudi Females.

Authors:  Lubna Ibrahim Al Asoom; Marwah Mansour Al Makhaita; Nazish Rafique; Dina Tariq Al Afandi; Waad Mohammed Al Otaibi; Hind Saleh Alsuwat; Mousa A Alaithan; Sayed AbdulAzeez; J Francis Borgio
Journal:  J Blood Med       Date:  2020-10-20

Review 4.  Genetic epidemiology of hemoglobinopathies among Iraqi Kurds.

Authors:  Nasir Al-Allawi; Sarah Al Allawi; Sana D Jalal
Journal:  J Community Genet       Date:  2020-11-22

5.  Reasons for Hospitalization of Sickle Cell Disease Patients in the Eastern Province of Saudi Arabia: A Single-Center Study.

Authors:  Ossama M Zakaria; Rayan A Buhalim; Faisal A Al Jabr; Mohammed N AlSaeed; Ibrahim A Al-Hajji; Yousif A Al Saleh; Mohammed A Buhalim; Abdulaziz M Al Dehailan
Journal:  Cureus       Date:  2021-11-06

6.  A Huge Subcapsular Splenic Cyst Like Hematoma in Sickle Cell Anemia.

Authors:  Ahmad M Odeh; Kawthar A Boumarah; Wejdan A Alsumaien; Mohmmed T Al-Abbad; Aminah H Al-Ali; Zainab A Alammar; Hesham Alsuqair; Abdulqader M Albeladi; Abdulmohsen Alsuwaigh; Ammar Omrani; Mohammed M Almuhanna; Zaki Busbaih; Hussain R Al-Shaban; Abrar A Aldhameen
Journal:  Cureus       Date:  2022-02-24

7.  Protocol for "Genetic composition of sickle cell disease in the Arab population: A systematic review".

Authors:  Fateen Ata; Zohaib Yousaf; Sundus Sardar; Saad Javed; Phool Iqbal; Ibraheem Khamees; Lujain Salahaldeen Malkawi; Mohamed A Yassin
Journal:  Health Sci Rep       Date:  2022-05-03

8.  Genotypic Diversity among Angolan Children with Sickle Cell Anemia.

Authors:  Mariana Delgadinho; Catarina Ginete; Brígida Santos; Armandina Miranda; Miguel Brito
Journal:  Int J Environ Res Public Health       Date:  2021-05-19       Impact factor: 3.390

9.  Diagnosis of Sickle Cell Disease and HBB Haplotyping in the Era of Personalized Medicine: Role of Next Generation Sequencing.

Authors:  Adekunle Adekile; Nagihan Akbulut-Jeradi; Rasha Al Khaldi; Maria Jinky Fernandez; Jalaja Sukumaran
Journal:  J Pers Med       Date:  2021-05-23
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.